`
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`_____________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`_____________
`
`PROLLENIUM US INC.,
`Petitioner,
`v.
`ALLERGAN INDUSTRIE, SAS,
`Patent Owner.
`_____________
`IPR2019-01505, Patent 8,450,475 B2
`IPR2019-01506, Patent 8,357,795 B2
`IPR2019-01508, Patent 9,238,013 B2
`IPR2019-01509, Patent 9,358,322 B2
`IPR2019-01617, Patent 8,822,676 B2
`IPR2019-01632, Patent 8,357,795 B2
`IPR2020-00084, Patent 9,089,519 B2
`_____________
`
`JOINT STIPULATION TO MODIFY DUE DATES 5-6
`IN SCHEDULING ORDER1
`
`
`
`
`
`
`
`
`
`
`
`1 Authorization for the use of a joint caption page was received on April 27, 2020.
`Neither party opposes the use of a joint caption page. An identical paper has been
`filed in each case recited in the consolidated caption.
`
`
`
`IPR2019-01505, IPR2019-01506, IPR2019-01508, IPR2019-01509,
`IPR2019-01617, IPR2019-01632, IPR2020-00084
`
`
`Prollenium US Inc. (“Petitioner”) and Allergan Industrie, SAS (“Patent
`
`Owner”), by and through their respective counsel of record, hereby stipulate as
`
`follows:
`
`On April 13, 2020, the Scheduling Order in the Inter Partes Review of U.S.
`
`Patent No. 8,450,475 (IPR2019-01505), U.S. Patent No. 8,357,795 (IPR2019-
`
`01506), U.S. Patent No. 9,238,013 (IPR2019-01508), U.S. Patent No. 9,358,322
`
`(IPR2019-01509), U.S. Patent No. 8,822,676 (IPR2019-01617), U.S. Patent No.
`
`8,357,795 (IPR2019-01632), and U.S. Patent No. 9,089,519 (IPR2020-00084) set
`
`forth “due dates for the parties to take action in this trial,” and further stated that
`
`the “parties may stipulate different dates for DUE DATES 1, 2, 5, and 6, as well as
`
`the portion of DUE DATE 3 related to Patent Owner’s sur-reply (earlier or later,
`
`but no later than DUE DATE 7).” Id. at 7.
`
`Patent Owner and Petitioner hereby stipulate to modify DUE DATES 5–6 as
`
`follows:
`
`DUE DATE 5:
`
`December 9, 2020
`
`DUE DATE 6:
`
`December 16, 2020
`
`This stipulation does not affect or otherwise modify any other due dates in
`
`the Scheduling Order.
`
`
`
`
`
`1
`
`
`
`IPR2019-01505, IPR2019-01506, IPR2019-01508, IPR2019-01509,
`IPR2019-01617, IPR2019-01632, IPR2020-00084
`
`
`
`
`
`Date: December 4, 2020
`
`
`
`Date: December 4, 2020
`
`
`
`
`
`
`
`Respectfully Submitted,
`
`/Warren Thomas/
`Warren J. Thomas
`Reg. No. 70,581
`Petitioner, Prollenium US Inc.
`
`/Anthony M. Insogna/
`Anthony M. Insogna
`Reg. No. 35,203
`Patent Owner, Allergan Industrie, SAS
`
`2
`
`
`
`
`
`CERTIFICATE OF SERVICE
`
`Pursuant to 37 C.F.R. §§ 42.6(e)(4) and consent of the Patent Owner, I certify
`that on December 4, 2020, a copy of Joint Stipulation to Modify Due Dates 5-6
`was served on the counsel of record by email to:
`aminsogna@jonesday.com
`tweisser@jonesday.com
`cplatt@jonesday.com
`sgeers@jonesday.com
`jhartjes@jonesday.com
`
`
`
`
`
`
`/Warren Thomas/
`Warren J. Thomas (Reg. No. 70,581)
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`